Literature DB >> 6283913

Calcium channel and prolactin release in rat clonal pituitary cells: effects of verapamil.

S Ozawa, N Kimura.   

Abstract

Effects of verapamil on membrane electrical properties and prolactin release were studied in a rat anterior pituitary cell line GH3. Thyrotropin-releasing hormone (TRH), Ba2+, and high concentration of K+ enhance the release of prolactin from GH3 cells. These stimulatory actions on prolactin release were inhibited by adding 10(-4) M verapamil to the bathing mediums. The maximum rate of rise of the Ca action potential was reduced to 17% of the control by addition of 10(-4) M verapamil. Ba2+ caused a sustained membrane depolarization because Ba2+ goes through the Ca channels and blocks the development of the delayed rectification. This effect of Ba2+ was also inhibited by verapamil. Verapamil suppressed both the Na+ and outward K+ currents in addition to the Ca2+ current. The suppressive effect of verapamil on the voltage-sensitive Ca current is probably responsible for the inhibition of TRH- and high K+-stimulated prolactin release because the suppression of the Na+ and outward K+ currents does not inhibit the stimulatory actions of these secretagogues.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283913     DOI: 10.1152/ajpendo.1982.243.1.E68

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Thyrotropin-releasing hormone stimulation of thyrotropin secretion is suppressed by calcium ion antagonists that block transmembrane influx and intracellular mobilization of calcium ion in human subjects.

Authors:  M Yamada; M Mori; M Yamaguchi; H Akiyama; S Shiono; I Kobayashi; S Kobayashi
Journal:  J Endocrinol Invest       Date:  1986-06       Impact factor: 4.256

2.  Growth hormone-releasing factor reduces voltage-gated Ca2+ channel current in rat GH3 cells.

Authors:  N Yamashita; Y Takuwa; E Ogata
Journal:  J Membr Biol       Date:  1985       Impact factor: 1.843

3.  Effect of 1,25-dihydroxyvitamin D3 and nifedipine on prolactin release in normal man.

Authors:  D Verbeelen; L Vanhaelst; M Fuss; A C Van Steirteghem
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.